Latest News- Immunology Market: Immunosuppressants is expected to lead the Type segment during 2024-2028

The Immunology Market is being driven by Growing organ transplantation

The Immunology Market is expected to grow at a CAGR of 9.45% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 65.8 billion. In the immunology market, the pipeline is brimming with potential immunological agents poised for approval, which will significantly expand treatment options and drive market growth. Currently, approximately 51 molecules are undergoing clinical trials globally, with 22 in Phase II, four in Phase III, 16 in Phase I, and the remainder in Phase I/II trials. One noteworthy molecule, risankizumab from AbbVie Inc., is in development in collaboration with Boehringer Ingelheim. This promising agent, which is undergoing clinical trials, holds immense potential for the immunology market. 

Get more information on Immunology Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Type
  • Immunosuppressants
  • Immuno boosters
• Distribution Channel
  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
• Geography
  • North America
    • US
  • Europe
    • Germany
    • UK
  • Asia
    • China
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Growing organ transplantation
• Growing cases of infectious diseases
• Hurdles in approval of biosimilars

However, the market also witnesses some limitations, which are as follows:

• Entry of biosimilars
• High cost of manufacturing coupled with strict regulations
• Lack of awareness of immunology

Benefits of Buying Global Immunology Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Immunology Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The immunology market encompasses various aspects of the immune system, including its response to infections, dysregulation in immune responses leading to disorders such as rheumatoid arthritis and psoriatic arthritis, and autoimmune diseases like Type 1 diabetes. Innovative therapies, including biosimilars, biologics, monoclonal antibodies, and immune checkpoint inhibitors, are utilized in hospital pharmacies to treat these conditions. Diagnostic tools like ELISA assays, flow cytometry, PCR-based diagnostics, and immunology therapies play a crucial role in identifying and managing immune-related disorders. Biotechnology advances continue to shape the landscape of immunology, with a focus on cancer, allergies, and infectious diseases.

Market Research Overview

The Immunology Market, a significant segment of the global Life Science Tools and Services Market, encompasses companies and solutions focused on research and development (R&D) of pharmaceuticals and biotechnology products related to the immune response and immune system. This includes the diagnosis and treatment of infections, immunological disorders such as rheumatoid arthritis, psoriatic arthritis, and type 1 diabetes, as well as the development of biosimilars, biologics, and monoclonal antibodies for autoimmune disorders. Key growth drivers for this market include an aging population, increasing prevalence of chronic illnesses, and environmental factors like toxic chemicals and gut dysbiosis. Technavio projects the global healthcare market, which includes the revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services, to experience significant growth due to these factors.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/